|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.145 EUR | -2.14% |
|
-18.79% | +31.91% |
| 2023 | Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | MEDESIS : Invest Securities confirms its recommendation | CF |
2,806623,84
•
•
•
•
•
•
•
;
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer
Medesis Pharma SA published this content on 31 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 March 2023 07:23:08 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.91% | 5.63M | |
| +7.52% | 113B | |
| +11.38% | 106B | |
| +1.48% | 22.27B | |
| -12.64% | 22.22B | |
| -5.10% | 19.43B | |
| -37.85% | 17.87B | |
| -8.58% | 17.24B | |
| +7.77% | 14.29B | |
| +37.41% | 12.52B |
MEDESIS PHARMA S.A. 
